Citius Pharmaceuticals's total assets for Q3 2025 were $127.68M, an increase of 5.10% from the previous quarter. CTXR total liabilities were $60.12M for the fiscal quarter, a 3.82% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.